权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Role of Parkin in Familial and Idiopathic Parkinson's Disease

Parkin 在家族性和特发性帕金森病中的作用

基本信息

批准号：
8451475
负责人：
Matthew J Lavoie
金额：
$ 36.93万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-07-01 至 2015-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8451475
关键词：
1-Methyl-4-phenylpyridinium Address Affect Apoptosis Apoptotic Autosomal Recesssive Juvenile Parkinsonism Axonal Transport Biochemical Biochemical Pathway Biological Biological Assay Biology Cell Culture Techniques Cell Fractionation Cell Survival Cells Cellular Stress Chimeric Proteins Collaborations Complex Cytoplasm Cytosol Data Defect Disease Dominant-Negative Mutation Etiology Evaluation Event Financial compensation Gene Mutation Genes Goals Half-Life Homeostasis Hydrogen Peroxide In Vitro Investigation Life Link Lysine Malignant Neoplasms Mass Spectrum Analysis Mediating Mitochondria Mitochondrial Proteins Mitotic Modeling Molecular Morphology Mus Nerve Degeneration Neurodegenerative Disorders Neurons Outcome Oxidative Stress PINK1 gene Parkin gene Parkinson Disease Pathogenesis Pathology Pathway interactions Patients Play Process Proteins Proteome Proteomics Reaction Recombinant Proteins Regulation Reporting Rest Risk Factors Role Rotenone Set protein Specificity Stable Isotope Labeling Stimulus Stress Stroke Substantia nigra structure System Therapeutic Intervention Ubiquitination Up-Regulation Validation Vitamin K 3 Western Blotting Work attenuation base biological adaptation to stress brain tissue cell injury cellular imaging improved in vitro activity in vivo innovation insight interest loss of function mutation meetings mitochondrial dysfunction mutant nervous system disorder neuron loss new therapeutic target novel parkin gene/protein protein function protein transport public health relevance response stressor synuclein trafficking ubiquitin-protein ligase

项目摘要

DESCRIPTION (provided by applicant): Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the near selective loss of neurons in the substantia nigra. While the etiology of the disease is unknown, genetic mutations responsible for familial forms of PD will likely provide critical molecular clues to the underlying mechanisms of idiopathic disease. Loss-of-function mutations in the ubiquitin E3 ligase parkin are the most common cause of autosomal recessive PD. Parkin is now widely recognized as a pro-survival protein rapidly up-regulated during cell injury. Parkin is believed to possess broad ranging effects on mitochondrial biology that are likely relevant to idiopathic PD. However, the biochemical substrates of these effects are largely unknown. The long-term goal of our work is to uncover the molecular machinery responsible for parkin's influence on mitochondria. This information will not only improve our understanding of an important neuronal stress response protein but will also elucidate new biochemical pathways likely involved in the selective neurodegeneration in PD. The experimental focus of this application is on the mitochondrial defects that result from neuronal deficiencies in parkin and identifying the proteins responsible. There are three specific aims. 1) Analyze the parkin-dependent ubiquitination of two novel parkin substrates involved in mitochondrial fission and apoptosis. We will determine the effects of endogenous parkin on protein half-life and localization, and the contribution of these candidate substrates on mitochondrial defects in parkin deficient neurons. 2) Analyze the mitochondrial consequences of parkin deficiency in primary cultured neurons, and examine enhanced vulnerabilities of parkin null neurons to stressors implicated in idiopathic PD. 3) Examine mitochondria-specific changes in protein trafficking and function that occur in parkin deficient neurons. The completion of these studies will establish mechanistic links between the E3 ligase activity of parkin and its function as a pro-survival stress response protein with mitochondrial influence. This work will elucidate novel biochemical pathways involved in the pathogenesis of PD and potentially uncover innovative targets for therapeutic intervention.

描述（由申请人提供）：帕金森病（PD）是一种进行性神经退行性疾病，其特征是黑质神经元的近选择性丧失。虽然疾病的病因尚不清楚，但家族性帕金森病的基因突变可能为特发性疾病的潜在机制提供关键的分子线索。泛素E3连接酶激酶的功能丧失突变是常染色体隐性遗传性帕金森病的最常见原因。Parkin蛋白目前被广泛认为是一种在细胞损伤过程中快速上调的促存活蛋白。帕金被认为对线粒体生物学具有广泛的影响，可能与特发性帕金森病有关。然而，这些作用的生化基础在很大程度上是未知的。我们工作的长期目标是揭示帕金森氏蛋白对线粒体影响的分子机制。这一信息不仅将提高我们对一种重要的神经元应激反应蛋白的理解，而且将阐明可能参与PD选择性神经变性的新的生化途径。该应用程序的实验重点是线粒体缺陷，由神经元缺陷导致的帕金和识别负责的蛋白质。有三个具体目标。1)分析参与线粒体分裂和凋亡的两种新型parkin底物的泛素化依赖性。我们将确定内源性帕金对蛋白质半衰期和定位的影响，以及这些候选底物对帕金缺乏神经元线粒体缺陷的贡献。2)分析原代培养神经元中帕金缺乏症对线粒体的影响，并检查帕金缺乏症神经元对特发性PD相关应激源的脆弱性增强。3)检查线粒体特异性改变蛋白运输和功能发生在帕金缺乏症神经元。这些研究的完成将建立parkin的E3连接酶活性与其作为线粒体影响的促生存应激反应蛋白的功能之间的机制联系。这项工作将阐明PD发病机制中的新的生化途径，并有可能发现治疗干预的创新靶点。